Clinical Cardiology Alert – February 1, 2009
February 1, 2009
View Issues
-
Diabetes and Revascularization Techniques: Some Good News!
Diabetics are known to have higher rates of restenosis after revascularization than non-diabetic subjects. -
Cilostazol Reduces Restenosis and Repeat Procedures after Peripheral Arterial Interventions
Percutaneous intervention for peripheral arterial disease (PAD) results in improvement in claudication symptoms but is complicated by a high rate of restenosis. -
Posterior ECG Leads Improve the Detection of Left Circumflex Coronary Artery Occlusion
Optimal management of transmural myocardial infarction (MI) depends on rapid reperfusion of the occluded infarct artery. -
Perioperative Beta Blockers
The ACC/AHA guidelines recommend perioperative beta blockers for those already on them, patients undergoing vascular surgery, or those having intermediate- to high-risk surgery with established coronary heart disease, or at high risk of having it. -
Cardiac Resynchronization in Mild Heart Failure Patients
The resynchronization reverses remodeling in Systolic Left Ventricular Dysfunction (REVERSE) trial tested the hypothesis that cardiac resynchronization therapy (CRT) would benefits patients with New York Heart Association (NYHA) functional class I and II heart failure and a prolonged QRS duration. -
Catheter Ablation vs Antiarrhythmic Drugs for Atrial Fibrillation
The catheter ablation versus antiarrhythmic Drugs for Atrial Fibrillation (A4) study compared radio-frequency catheter ablation to antiarrhythmic therapy in selected patients with paroxysmal atrial fibrillation (PAF). -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.